Aktuellt
SENASTE
Redeye provides an in-depth review of Episurf Medical’s Q4 report and events during and after the quarter. The report contained no major surprises; however, we are encouraged by the progression in the current FDA clearance process relating to Episealer MTP and the new distribution agreement with Joint Operations Ltd.
LÄS MER
